Defendant shall be punished by a fine of KRW 7,000,000.

If the defendant does not pay the above fine, the amount of KRW 100,000 shall be paid.

Punishment of the crime

[Presumption Facts] Non-pharmaceutical drugs refers to textile and rubber products or similar products used for the purpose of treating, alleviating, treating, or preventing human or animal diseases, which are designated by the Minister of Food and Drug Safety, and health Masck, which are products used for the purpose of protecting respiratory devices from sulfur harmful substances, such as yellow dust and fine dust, or infected sources, constitutes non-pharmaceutical drugs subject to the Pharmaceutical Affairs Act pursuant to the public notice of the designation of the scope of non-pharmaceutical drugs (Notice of the Ministry of Food and Drug Safety, No. 2019-86 of the Ministry of Food and Drug Safety).

From the beginning of 2020, the Health Authority recommended to wear a garrosk for health by spreading over the world and wearing a garrosk for health, and the demand of the garros or 19 increased in order to prevent the spread of the garros or 19.

As a result, the Defendant, along with B and C, purchased a fake health garl which is distributed in the form of “pactk” without stating the name, the trade name and address, capacity or weight of manufacturers or importers, manufacturing number and time limit, and the letters of non-pharmaceuticals on the containers or packages of non-pharmaceuticals, other than pharmaceutical products, and then stored them for sales purposes or conspired to sell them by deceiving them as if they were refined.

[2] Criminal facts B, while purchasing an industrial garment from D, E, etc., took a photograph of the product license, test and inspection record, etc. of a gark (KF94) and instruct C and the Defendant to sell them. The Defendant and C, according to B’s instructions, advertised the industrial garch as “free gark (KF)’s health garment” while selling online garment garments through online mulgs, straws, etc., and transfers the product license, test and inspection record to B and then, upon receipt of deposit of sales proceeds, transfer the product back to B.